(PRWEB) July 31, 2013
The law firm McSweeney / Langevin is now providing legal advice to men and young boys who have taken Risperdal and experienced breast growth, puffy nipples, enlarged nipples, breast pain, nipple discharge, a gynecomastia diagnosis, and/or a mastectomy to remove breast tissue.
Risperdal (risperidone) is a medication prescribed to treat psychiatric disorders including schizophrenia, some autistic disorders, and occasionally depression. Risperdal is usually prescribed to boys and young men.
A June 2006 study conducted by Duke University researchers found the risk of male breast tissue growth following the use of Risperdal was greater as compared to other antipsychotic drugs.
According to a September 11, 2012 Forbes article, "J&J Sees Male Breasts and Quickly Settles Risperdal Suit," Risperdal stimulated the production of prolactin, which is a hormone released by the pituitary gland that stimulates breast development.
Forbes speculated that Johnson & Johnson may have settled several of the claims in order to avoid having former FDA Commissioner David Kessler called to the stand as a witness. In addition, Forbes suggests Johnson & Johnson promoted Risperdal for non-approved uses in violation of the Federal Food, Drug, and Cosmetic Act.
McSweeney / Langevin is offering free legal consultations to anyone injured as a result of Risperdal at 1-800-888-4425 or info(at)WeStrikeBack(dot)com. The consultation is private and confidential.